Welcome to LookChem.com Sign In|Join Free
  • or
H-D-PHE-D-PHE-OH, also known as enkephalin, is a dipeptide consisting of two phenylalanine amino acids linked by a peptide bond. It is a significant compound in peptide synthesis and structure-activity relationship studies, playing a crucial role in the development of peptidomimetics and potential therapeutic agents.
Used in Pharmaceutical Development:
H-D-PHE-D-PHE-OH is used as a building block for creating peptidomimetics, which are small molecule compounds designed to mimic the structure and function of peptides. These peptidomimetics have potential applications in various therapeutic areas, including pain management, inflammation, and infectious diseases.
Used in Neuroscience Research:
H-D-PHE-D-PHE-OH is used as a research tool for studying the structure and function of opioid receptors, which are involved in modulating pain perception. Its interaction with these receptors can provide insights into the development of novel pain management therapies.
Used in Drug Discovery:
H-D-PHE-D-PHE-OH has potential therapeutic applications in drug development, particularly in the field of neuroscience. Its ability to target opioid receptors and modulate pain perception makes it a promising candidate for the development of new analgesic drugs.

58607-69-5

Post Buying Request

58607-69-5 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

58607-69-5 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 58607-69-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,8,6,0 and 7 respectively; the second part has 2 digits, 6 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 58607-69:
(7*5)+(6*8)+(5*6)+(4*0)+(3*7)+(2*6)+(1*9)=155
155 % 10 = 5
So 58607-69-5 is a valid CAS Registry Number.
InChI:InChI=1/C18H20N2O3/c19-15(11-13-7-3-1-4-8-13)17(21)20-16(18(22)23)12-14-9-5-2-6-10-14/h1-10,15-16H,11-12,19H2,(H,20,21)(H,22,23)/t15-,16-/m1/s1

58607-69-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name (2R)-2-[[(2R)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoic acid

1.2 Other means of identification

Product number -
Other names D-Phenylalanine,D-phenylalanyl

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:58607-69-5 SDS

58607-69-5Relevant academic research and scientific papers

Search for fibrous aggregates potentially useful in regenerative medicine formed under physiological conditions by self-assembling short peptides containing two identical aromatic amino acid residues

Fraczyk, Justyna,Lipinski, Wojciech,Chaberska, Agata,Wasko, Joanna,Rozniakowski, Kamil,Kaminski, Zbigniew J.,Bogun, Maciej,Draczynski, Zbigniew,Menaszek, Elzbieta,Stodolak-Zych, Ewa,Kaminska, Marta,Kolesinska, Beata

supporting information, (2018/03/21)

This study investigates the propensity of short peptides to self-organize and the influence of aggregates on cell cultures. The dipeptides were derived from both enantiomers of identical aromatic amino acids and tripeptides were prepared from two identica

D -amino acids boost the selectivity and confer supramolecular hydrogels of a nonsteroidal anti-inflammatory drug (NSAID)

Li, Jiayang,Kuang, Yi,Gao, Yuan,Du, Xuewen,Shi, Junfeng,Xu, Bing

supporting information, p. 542 - 545 (2013/03/14)

As systemically used therapeutics for treating acute or chronic pains or inflammations, nonsteroidal anti-inflammatory drugs (NSAIDs) also associate with the adverse gastrointestinal and renal effects and cardiovascular risks. Thus, it is beneficial to develop topical gels that selectively inhibit cyclooxygenase-2 (COX-2) for the management of local inflammation. In this work, we demonstrate that the covalent conjugation of d-amino acids to naproxen (i.e., a NSAID) not only affords supramolecular hydrogelators for the topical gels but also unexpectedly and significantly elevates the selectivity toward COX-2 about 20× at little expense of the activity of naproxen. This work illustrates a previously unexplored approach that employs d-amino acids for the development of functional molecules that have dual or multiple roles and exceptional biostability, which offers a new class of molecular hydrogels of therapeutic agents.

Aminolytic reaction catalyzed by d-stereospecific amidohydrolases from Streptomyces spp

Arima, Jiro,Ito, Hitomi,Hatanaka, Tadashi,Mori, Nobuhiro

experimental part, p. 1460 - 1469 (2012/01/12)

From investigation of 2000 soil isolates, we identified two serine-type amidohydrolases that can hydrolyze d-aminoacyl derivatives from the culture supernatant of Streptomyces species 82F2 and 83D12. The enzymes, redesignated as 82F2-DAP and 83D12-DAP, were purified for homogeneity and characterized. Each enzyme had molecular mass of approximately 40 kDa, and each showed moderate stability with respect to temperature and pH. Among hydrolytic activities toward d-aminoacyl-pNAs, the enzymes showed strict specificity toward d-Phe-pNA, but showed broad specificity toward d-aminoacyl esters. The specific activity for d-Phe-pNA hydrolysis of 82F2-DAP was ten-fold higher than that of 83D12-DAP. As a second function, each enzyme showed peptide bond formation activity by its function of aminolysis reaction. Based on results of d-Phe-d-Phe synthesis under various conditions, we propose a reaction mechanism for d-Phe-d-Phe production. Furthermore, the enzymes exhibited peptide elongation activity, producing oligo homopeptide in a one-pot reaction. We cloned the genes encoding each enzyme, which revealed that the primary structure of each enzyme showed 30-60% identity with those of peptidases belonging to the clan SE, S12 peptidase family categorized as serine peptidase with d-stereospecificity.

Peptide bond formation by aminolysin-A catalysis: A simple approach to enzymatic synthesis of diverse short oligopeptides and biologically active puromycins

Usuki, Hirokazu,Yamamoto, Yukihiro,Arima, Jiro,Iwabuchi, Masaki,Miyoshi, Shozo,Nitoda, Teruhiko,Hatanaka, Tadashi

supporting information; experimental part, p. 2327 - 2335 (2011/05/02)

A new S9 family aminopeptidase derived from the actinobacterial thermophile Acidothermus cellulolyticus was cloned and engineered into a transaminopeptidase by site-directed mutagenesis of catalytic Ser491 into Cys. The engineered biocatalyst, designated aminolysin-A, can catalyze the formation of peptide bonds to give linear homo-oligopeptides, hetero-dipeptides, and cyclic dipeptides using cost-effective substrates in a one-pot reaction. Aminolysin-A can recognize several C-terminal-modified amino acids, including the l- and d-forms, as acyl donors as well as free amines, including amino acids and puromycin aminonucleoside, as acyl acceptors. The absence of amino acid esters prevents the formation of peptides; therefore, the reaction mechanism involves aminolysis and not a reverse reaction of hydrolysis. The aminolysin system will be a beneficial tool for the preparation of structurally diverse peptide mimetics by a simple approach.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 58607-69-5